Western Australian Consolidated Regulations Western Australian Consolidated Regulations (1) Until in any
particular case such authority is withdrawn —
(a) a
medical practitioner; and
(b) a
pharmacist employed in dispensing medicines at any public hospital or at a
pharmacy for which a pharmacist’s licence is held; and
[(c) deleted]
(d) a
veterinary surgeon; and
(e) an
analyst registered under the Health Act 1911 ; and
(f) a
registered nurse employed in a hospital (so far as the possession or use of
such poison included in Schedule 8 is required in connection with its
administration to a patient under the instruction of a medical practitioner);
and
(ga) a
registered midwife employed in a hospital (so far as the possession or use of
such poison included in Schedule 8 is required in connection with its
administration to a patient under the instruction of a medical practitioner);
and
(g) a
person in possession of a permit granted by the CEO under these regulations,
is, subject to these
regulations, hereby authorised to procure and be in possession of any poison
included in Schedule 8 for the purpose of his profession or employment.
(2) A person in
respect of whom a prescription for a poison included in Schedule 8 is
issued is hereby authorised to procure and have possession of the poison
included in Schedule 8 to the extent specified in the prescription.
(3) The authority
under this regulation to procure and be in the possession of any poison
included in Schedule 8 does not entitle the holder to procure or have in
his possession any poison included in Schedule 8 in any quantity greater
than is permitted by the CEO.
(4) Until in any
particular case such authority is withdrawn a dentist is, subject to these
regulations and for the purpose of his profession, hereby authorised to
procure and be in possession of the following poisons included in
Schedule 8 in quantities not greater than those set out
hereunder —
|
PETHIDINE in a form prepared for injection with a total pethidine content of
600 mg |
|
PAPAVERETUM, in tablet form, with a total papaveretum content of 240 mg |
|
CODEINE PHOSPHATE, in tablet form, with a total codeine phosphate content of
900 mg |
|
METHADONE, in tablet form, with a total methadone content of 240 mg |
|
MORPHINE, in a form prepared for injection, with a total morphine content of
180 mg |
|
OXYCODONE, in tablet form, with a total oxycodone content of 120 mg |
|
PENTAZOCINE, in a form prepared for injection, with a total pentazocine
content of 360 mg. |
[Regulation 42 amended in Gazette
9 Feb 1970 p. 370; 29 Jun 1984 p. 1784;
8 Feb 1985 p. 520; 25 Jun 1993 p. 3085;
26 May 1994 p. 2201; 19 Mar 1996 p. 1227;
27 Nov 1998 p. 6344; 15 Dec 2006 p. 5630;
7 Nov 2008 p. 4811‑12; 27 Apr 2010
p. 1583‑4; 1 Oct 2010 p. 5079‑80.]
[Heading deleted in Gazette 12 Aug 2003 p. 3663.]